Linzess and Combigan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Linzess (linaclotide) and Combigan (brimonidine tartrate; timolol maleate). Common drug interactions include diarrhoea among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Linzess and Combigan. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Linzess?

Linzess has active ingredients of linaclotide. It is often used in constipation. eHealthMe is studying from 24,086 Linzess users. Check the latest studies of Linzess.

What is Combigan?

Combigan has active ingredients of brimonidine tartrate; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 7,810 Combigan users. Check the latest studies of Combigan.



On Jul, 10, 2026

38 people who take Linzess and Combigan together, and have interactions are studied.

Linzess and Combigan drug interactions.

What are the common drug interactions of Linzess and Combigan, by gender? *:

female:

  1. Diarrhoea
  2. Fatigue (feeling of tiredness)
  3. Back pain
  4. Micturition urgency (urgency to pass the urine)
  5. Abdominal distension
  6. Abdominal discomfort
  7. Eye irritation
  8. Abdominal pain
  9. Flatulence (flatus expelled through the anus)
  10. Arthralgia (joint pain)

male:

  1. Fall
  2. Mobility decreased (ability to move is reduced)
  3. Coronavirus test positive
  4. Death
  5. Depression
  6. Drug hypersensitivity
  7. Hospitalisation
  8. Hypotension (abnormally low blood pressure)
  9. Influenza
  10. Influenza like illness

What are the common drug interactions of Linzess and Combigan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Fall
  2. Mobility decreased (ability to move is reduced)
  3. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  4. Tooth disorder (tooth disease)
  5. Depression
  6. Fatigue (feeling of tiredness)
  7. Abdominal distension
  8. Drug ineffective
  9. Weight increased

50-59:

n/a

60+:

  1. Fatigue (feeling of tiredness)
  2. Diarrhoea
  3. Erythema (redness of the skin)
  4. Hospitalisation
  5. Hypotension (abnormally low blood pressure)
  6. Influenza
  7. Influenza like illness
  8. Pruritus (severe itching of the skin)
  9. Swollen tongue (swelling of tongue)
  10. Weight fluctuation

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 9 people, 23.68%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 13.16%
  3. Parkinson's Disease: 3 people, 7.89%
  4. Irritable Bowel Syndrome: 3 people, 7.89%
  5. Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 2 people, 5.26%
  6. Hereditary Neuropathic Amyloidosis (hereditary- diseases resulting from abnormal deposition of certain proteins (amyloid) in various bodily areas by problems with signals from the nerves): 2 people, 5.26%
  7. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Linzess and Combigan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Linzess and Combigan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Combigan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linzess and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Combigan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on linaclotide and brimonidine tartrate; timolol maleate (the active ingredients of Linzess and Combigan, respectively), and Linzess and Combigan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: